ABH Healthcare Limited
SMEABH • BSE, NSE
Issue details
Price band
₹96 - ₹102
Lot size
1,200 shares
Issue size
₹34.98 Cr
Min. investment
₹1,22,400
Registrar
Bigshare Services
Grey market premium
N/A
Save your family's PANs once and check allotment for everyone the moment results are out.
Sign in with a mobile OTP. It takes 20 seconds.
IPO Timeline
Open
24 Aug
Close
27 Aug
Allotment
28 Aug
Listing
1 Sep
- Refunds & demat credit
- 29 Aug 2026
- Mandate end
- 11 Sep 2026
We calculate these dates from the allotment and close dates, so please treat them as indicative.
Application size
| Category | Minimum | Maximum |
|---|---|---|
| Retail | 1,200shares 1 lot · ₹1,22,400 | 1,200shares 1 lot · ₹1,22,400 |
| HNI | 2,400shares 2 lots · ₹2,44,800 | No limit funds permitting |
Based on the upper price band of ₹102 and a lot of 1,200 shares.
Subscription
| Quota | Shares offered | Shares bid | Applications | Subscribed |
|---|---|---|---|---|
| Total | — | 48,54,000 | 1,154 | — |
Last updated 13 days ago.
Issue structure
Face value
₹10 per share
Issue type
Bookbuilding IPO
Sale type
Fresh capital only
Fresh issue
₹33 Cr
32,56,800 shares
Shares pre-issue
80,00,000
Shares post-issue
1,14,29,600
Valuation & ratios
| Metric | Pre-IPO | Post-IPO |
|---|---|---|
| EPS | 7.05 | 4.93 |
| P/E | 14.47 | 20.69 |
| Market cap | ₹82Cr. | ₹116.58 Cr |
| KPI | Mar 31, 2026 |
|---|---|
| ROE | 39.07% |
| ROCE | 19.09% |
| Debt/Equity | 3.20 |
| RoNW | 39.07% |
| PAT Margin | 10.74% |
| EBITDA Margin | 28.03% |
| NAV | 21.58 |
| Price to Book Value | 4.73 |
Financials
| Metric | 31 Mar 2026 | 31 Mar 2025 | 31 Mar 2024 |
|---|---|---|---|
| Total income | 52.59 | 49.32 | 41.39 |
| Profit after tax | 5.64 | 5.35 | 1.66 |
| EBITDA | 14.72 | 13.2 | 6.89 |
| Net worth | 17.27 | 11.6 | 6.3 |
| Assets | 85.27 | 63.9 | 51.35 |
| Reserves & surplus | 9.34 | 9.69 | 4.35 |
| Total borrowing | 45.75 | 33.78 | 30.59 |
Figures in ₹ crore, as reported by the company in its offer document.
Objects of the issue
- 1.Repayment / prepayment, in part or full, of certain of borrowings₹17 Cr
- 2.Funding working capital requirements₹5 Cr
- 3.Funding inorganic growth through unidentified acquisitions and general corporate purposes (collectively referred to as Objects)—
What the company says it intends to do with the money raised.
Recent comparable IPOs
| Company | Issue price | P/E | Listing close | Listing gain |
|---|---|---|---|---|
| Bio Medica Laboratories Ltd.SME | ₹139 | 13.03 | ₹115.80 | -16.69% |
| Goldline Pharmaceutical Ltd.SME | ₹43 | 10.47 | ₹56.77 | +32.02% |
| Speciality Medicines Ltd.SME | ₹124 | 9.27 | ₹125.90 | +1.53% |
| Accretion Nutraveda Ltd.SME | ₹129 | 26.27 | ₹191.20 | +48.22% |
| KRM Ayurveda Ltd.SME | ₹135 | 17.32 | ₹180.70 | +33.85% |
| Curis Lifesciences Ltd.SME | ₹128 | 12.44 | ₹141.00 | +10.16% |
| Aptus Pharma Ltd.SME | ₹70 | 11.29 | ₹84.84 | +21.20% |
| Hexagon Nutrition Ltd.Mainboard | ₹45 | 22.69 | ₹53.19 | +18.20% |
| Sai Parenteral's Ltd.Mainboard | ₹392 | 72.19 | ₹405.70 | +3.49% |
| Corona Remedies Ltd.Mainboard | ₹1062 | 43.47 | ₹1,438.40 | +35.44% |
| Rubicon Research Ltd.Mainboard | ₹485 | 55.75 | ₹628.20 | +29.53% |
| Amanta Healthcare Ltd.Mainboard | ₹126 | 34.59 | ₹141.75 | +12.50% |
| Anlon Healthcare Ltd.Mainboard | ₹91 | 17.67 | ₹91.73 | +0.80% |
Past listing performance of comparable issues. This is not a forecast: listing gains vary widely and can turn negative.
Issue fundamentals compiled from the company's offer document via Chittorgarh, last read 19 Aug 2026. Always verify against the RHP before applying.